Palvella Therapeutics, Inc.
PVLA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583648
In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Palvella Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +8 vs. Q4 2024
- Shares held
- 5.12M
- +1.09M (+27.0%) vs. Q4 2024
- Total value
- $143.4M
- +$95.0M (+196.2%) vs. Q4 2024
- New holders
- 15
- 9 more added
- Sold out
- 7
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PVLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $2.15B |
| Q1 2026 | 180 | $1.64B |
| Q4 2025 | 140 | $1.02B |
| Q3 2025 | 100 | $534.5M |
| Q2 2025 | 67 | $133.2M |
| Q1 2025 | 41 | $143.4M |
| Q4 2024 | 33 | $48.4M |
| Q3 2024 | 25 | $10.1M |
| Q2 2024 | 20 | $3.57M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Palvella Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 2 | $0 | 0.00% | +2 | New |
| JPMorgan Chase & Co | 3 | $84 | 0.00% | −23−88.5% | Reduced |
| Jones Financial Companies LLLP | 3 | $84 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 5 | $128 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 14 | $392 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $1.40K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 63 | $1.76K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 312 | $8.73K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,246 | $62.9K | 0.00% | +1,138+102.7% | Added |
| Spire Wealth Management | 2,516 | $70.4K | 0.00% | +2,516 | New |
| Bank of America Corp | 7,609 | $213.0K | 0.00% | +7,597+63,308.3% | Added |
| Balyasny Asset Management LLC | 8,176 | $228.8K | 0.00% | +8,176 | New |
| Morgan Stanley | 9,907 | $277.3K | 0.00% | +9,816+10,786.8% | Added |
| UBS Group AG | 10,054 | $281.4K | 0.00% | +9,852+4,877.2% | Added |
| State Street Corp | 12,062 | $337.6K | 0.00% | +12,062 | New |
| Deltec Asset Management LLC | 12,500 | $349.9K | 0.08% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,258 | $427.1K | 0.00% | −6,113−28.6% | Reduced |
| Northern Trust Corp | 16,635 | $465.6K | 0.00% | +16,635 | New |
| Toronto Dominion Bank | 18,872 | $528.2K | 0.00% | +5,661+42.9% | Added |
| Goldman Sachs Group Inc | 19,053 | $533.3K | 0.00% | +19,053 | New |
| Cresset Asset Management, LLC | 20,911 | $585.3K | 0.00% | 00.0% | Unchanged |
| Strid Group, LLC | 29,219 | $817.8K | 0.13% | +29,219 | New |
| Marshall Wace, LLP | 30,345 | $849.4K | 0.00% | +30,345 | New |
| DAFNA Capital Management LLC | 43,348 | $1.21M | 0.34% | −28,104−39.3% | Reduced |
| UBS Oconnor LLC | 48,664 | $1.36M | 0.03% | +48,664 | New |
| AWM Investment Company, Inc. | 69,416 | $1.94M | 0.27% | +69,416 | New |
| Royce & Associates LP | 71,514 | $2.00M | 0.02% | +71,514 | New |
| Geode Capital Management, LLC | 94,199 | $2.64M | 0.00% | +79,929+560.1% | Added |
| BlackRock, Inc. | 110,758 | $3.10M | 0.00% | +97,820+756.1% | Added |
| Susquehanna International Group, LLP | 114,388 | $3.20M | 0.01% | +114,388 | New |
| Vanguard Group Inc | 138,433 | $3.87M | 0.00% | +127,091+1,120.5% | Added |
| Blue Owl Capital Holdings LP | 140,259 | $3.93M | 1.27% | −109,803−43.9% | Reduced |
| Opaleye Management Inc. | 172,357 | $4.82M | 1.07% | +172,357 | New |
| Woodline Partners LP | 194,167 | $5.43M | 0.04% | +194,167 | New |
| Nantahala Capital Management, LLC | 250,062 | $7.00M | 0.58% | 00.0% | Unchanged |
| Millennium Management LLC | 269,837 | $7.55M | 0.01% | +269,837 | New |
| Adams Street Partners LLC | 409,666 | $11.5M | 10.15% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 679,486 | $19.0M | 3.39% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 690,012 | $19.3M | 0.88% | +36,120+5.5% | Added |
| BVF Inc | 696,555 | $19.5M | 0.79% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 714,463 | $20.0M | 0.81% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −144,641−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −42,130−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,408−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,549−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |